The Epoch Times
The Epoch Times
Focus

csl

Australia News
Australia News
|
Monica O’Shea

CSL Delivers $2.9 Billion Profit, 110 Million Flu Vaccine Doses

CSL said developing new and better vaccines is a strategic priority for the company going forward.
Aug 13, 2024
|
Monica O’Shea
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
CSL Delivers $2.9 Billion Profit, 110 Million Flu Vaccine Doses
Aug 13
|
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
Australia News
Australia News
|
Celene Ignacio

Groundbreaking Asthma Drug Could Revolutionize Treatment

Sep 12, 2023
|
Celene Ignacio
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
Groundbreaking Asthma Drug Could Revolutionize Treatment
Sep 12
|
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
Vaccines & Safety
Vaccines & Safety
|
Jessie Zhang

Australia Inks Next-Gen mRNA Technology Deal With US

Nov 02, 2022
|
Jessie Zhang
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
Australia Inks Next-Gen mRNA Technology Deal With US
Nov 02
|
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
Australia News
Australia News
|
Marina Zhang

Australian University to Collaborate with Moderna for mRNA Vaccine Research

Mar 10, 2022
|
Marina Zhang
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
Australian University to Collaborate with Moderna for mRNA Vaccine Research
Mar 10
|
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
Australia News
Australia News
|
Marina Zhang

Australia Approves First Cell-Based Flu Vaccines For Kids Aged Two and Older

Mar 08, 2022
|
Marina Zhang
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
Australia Approves First Cell-Based Flu Vaccines For Kids Aged Two and Older
Mar 08
|
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
home-iconepochtv-iconhealth-iconbright-iconepochfun-icon
The Epoch Times
Copyright © 2000 - 2025 The Epoch Times Association Inc. All Rights Reserved.